Sign in →

Test Code FMPP2 Myocarditis/Pericarditis Panel


Specimen Required


Container/Tube: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 2 mL

Acceptable: SST

Collection Instructions: Draw blood in a plain red top tube(s), serum gel tube is acceptable. Spin down and send 2 mL of serum ambient in a plastic vial.


Secondary ID

75830

Profile Information

Test ID Reporting Name Available Separately Always Performed
ECH_1 Echovirus Antibody Panel, Serum No Yes
FINFL Influenza Types A and B Ab, Serum No Yes
FFCPA Chlamydophila pneumoniae Ab IgG/A/M No Yes

Method Name

Complement Fixation (CF)/Immunofluorescence Assay (IFA)

Reporting Name

Myocarditis/Pericarditis Panel

Specimen Type

Serum

Specimen Minimum Volume

1 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Ambient (preferred) 7 days
  Frozen  30 days
  Refrigerated  14 days

Reject Due To

Gross Hemolysis Reject
Gross Lipemia Reject
Gross Icterus Reject
Other reasons for rejection Specimens other than serum collected in Red top or SST

Reference Values

MYOCARDITIS-PERICARDITIS PANEL

 

ECHOVIRUS ANTIBODIES, SERUM

REFERENCE RANGE: <1:8

 

INTERPRETIVE CRITERIA:

<1:8 Antibody Not Detected

>or=1:8 Antibody Detected

 

Single titers >or=1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable cross-reactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.

 

INFLUENZA TYPE A AND B ANTIBODIES, SERUM

REFERENCE RANGE: <1:8

 

INTERPRETIVE CRITERIA:

<1:8 Antibody Not Detected

>or=1:8 Antibody Detected

 

Single titers of >or=1:64 are indicative of recent infection. Titers of 1:8 and 1:32 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.

 

CHLAMYDOPHILA PNEUOMIAE ANTIBODIES (IgG, IgA, IgM)

REFERENCE RANGE:

IgG <1:64

IgA <1:16

IgM <1:10

 

The immunofluorescent detection of specific antibodies to Chlamydophila pneumoniae may be complicated by cross-reactive antibodies, non-specific antibody stimulation, or past exposure to similar organisms such as C. psittaci and Chlamydia trachomatis. IgM titers of 1:10 or greater usually indicate recent infection, and any IgG titer may indicate past exposure. IgA is typically present at low titers during primary infection but may be elevated in recurrent exposures or in chronic infection.

Day(s) Performed

Tuesday through Saturday

Report Available

4 to 11 days

Performing Laboratory

Quest Diagnostics

Test Classification

This test was developed, and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

CPT Code Information

86632

86631 x 2

86658 x 5

86710 x 2

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FMPP2 Myocarditis/Pericarditis Panel Not Provided

 

Result ID Test Result Name Result LOINC Value
Z2309 Echovirus 4 Ab 5143-3
Z5241 C. pneumoniae IgG 6913-8
Z0364 Influenza A Ab 5229-0
Z0365 Influenza B Ab 5230-8
Z5242 C. pneumoniae IgA 6912-0
Z2310 Echovirus 7 Ab 6922-9
Z2311 Echovirus 9 Ab 5147-4
Z5243 C. pneumoniae IgM 6914-6
Z5244 Interpretation 50612-1
Z2313 Echovirus 11 Ab 6708-2
Z2314 Echovirus 30 Ab 6392-5